Sepsis:KnowFromDay1

bioMérieux

Logo for Sepsis:KnowFromDay1

Sepsis is a critical, life-threatening condition, which results in more than 200,000 deaths in the U.S. every year. The SepsisKnowFromDay1 podcast series, sponsored by bioMérieux, features panel discussions and presentations by experts in the fields of diagnostics, critical care, emergency medicine and infectious diseases in the diagnosis and management of this complex condition. Over the past decade, numerous scientific and clinical studies have investigated the use of a novel biomarker known as procalcitonin, or PCT, as a diagnostic test to aid in the assessment of sepsis. This series provides a forum for scientific exchange and the sharing of experiences to help in the understanding and management of patients suspected of having sepsis. Please subscribe to the podcast to receive the latest episodes as they are released. Additionally, we encourage you to share this podcast series with your friends and colleagues. Additional podcasts and webinars from bioMérieux on how industry experts utilize procalcitonin and other clinical information to better assess and manage patients can also be found at http://sepsisknowfromday1.com/

Sepsis is a critical, life-threatening condition, which results in more than 200,000 deaths in the U.S. every year. The SepsisKnowFromDay1 podcast series, sponsored by bioMérieux, features panel discussions and presentations by experts in the fields of diagnostics, critical care, emergency medicine and infectious diseases in the diagnosis and manag... Show more

Publisher Website | On Android | On iTunes | Feed XML

Related: medicine science-medicine health

Share: Share on Facebook Share on Twitter Share on Google Plus